JLABS

A great idea can come from anywhere. JLABS is the global incubator network of @JNJNews.

Community Guidelines:

[JLABS @JLABS]

Our latest webinar on "deep healing" in chronic autoimmune disease explores what it means to move beyond controlling the symptoms, and looks to restore things like tissue structure and barrier integrity. Watch it here: https://t.co/w3kqkebVv9

[JLABS @JLABS]

Now that BIO is over, connections have been made, and partnerships have been solidified, we’re excited to see what the next 12 months bring.

[Johnson & Johnson Innovation @JNJInnovation]

Our leaders are back from BIO and are excited to share their insights from their time onsite with team members. The future of biotech is bright & we’re excited to be a part of it!

[JLABS @JLABS]

We’re proud to sponsor the Curebound Cancer Challenge. Join Team Johnson & Johnson as we run, walk, and ride to accelerate cancer research and move closer to cures. Be part of the impact:

[JLABS @JLABS]

Our oncology team is heading to Seattle this July for an exclusive scientific symposium with bold oncology innovators. Attend the program and be part of the conversation driving innovation in lung cancer. Register today! https://t.co/DuwBS0UVmP

[JLABS @JLABS]

Did you catch today’s Fireside Chat? We’re so thrilled to have John Reed and Nauman Shah representing Johnson & Johnson at BIO this year!

[Johnson & Johnson Innovation @JNJInnovation]

What an amazing Fireside Chat! John Reed and Nauman Shah sat down to speak more on the transformational therapies developed at Johnson & Johnson, how we partner, and the future of innovative medicine.

[JLABS @JLABS]

What are you hoping to gain from attending #BIO2026?

[JLABS @JLABS]

Public-private-partnerships can help extend the runway for startups. It allows them to generate additional data before their next investment round, while getting access to valuable expertise and networks. Learn more in our latest blog: https://t.co/SX9e967N0Z

[JLABS @JLABS]

Apply today for the chance to present to J&J leadership!

Deadline is approaching: July 1

https://t.co/Pv0jIoovjV

[Johnson & Johnson Innovation @JNJInnovation]

Have promising science focused on solid tumor treatment?

Apply by July 1 for a chance to present to J&J leadership.

https://t.co/J84gp2XxY4

[JLABS @JLABS]

What features do you find valuable in a newsletter?

[JLABS @JLABS]

Do you have a big idea with the potential to transform the treatment of solid tumors? Learn more and apply by July 1.

https://t.co/Pv0jIoovjV

[Johnson & Johnson Innovation @JNJInnovation]

Submit your promising ideas with the potential to deliver superior safety and efficacy in the treatment of solid tumors for the chance to present to J&J leaders.

Apply by July 1. https://t.co/J84gp2XxY4

[JLABS @JLABS]

Lung cancer is one of the most pressing global health challenges today, and on July 6, we are bringing together leaders in oncology research, innovation, and investment in Seattle for an impactful scientific symposium. Reserve your spot today. https://t.co/gUc8yVOzw3

[JLABS @JLABS]

What are you most looking forward to at the BIO International Convention?

[JLABS @JLABS]

Looking forward to the exciting partnering conversations onsite and making new connections in this space. Will we see you there?

[Johnson & Johnson Innovation @JNJInnovation]

The biotech industry is driven by purpose, and next month, we’ll be joining thousands of others in the industry at BIO 2026 to discuss solutions to impossible problems, avenues to achieve better outcomes, and our ‘why’.

[JLABS @JLABS]

Summer is here - what's on the calendar?

[JLABS @JLABS]

Join Johnson & Johnson for R&D in the age of AI — a forum on innovation, strategy, and collaboration. Hear directly from leaders, engage in Q&A, and network with industry peers. Registration is open. Don’t miss it. https://t.co/mqoVV2y8KT

[JLABS @JLABS]

Are you working on the next wave of innovation in autoimmune disease? Join us for an event focused on moving beyond inflammation control to enable deep healing. Register here: https://t.co/3u358Wm8KB

[JLABS @JLABS]

Which mental health advancement is the most critical need?

[JLABS @JLABS]

Let's move beyond inflammation control to enable deep healing: restoring tissue structure, barrier integrity and homeostatic set points for durable patient outcomes. https://t.co/3u358Wm8KB

[Johnson & Johnson Innovation @JNJInnovation]

Are you an innovator in autoimmune disease? Join J&J to explore innovations moving beyond remission, as well as collaboration opportunities to bring these to patients. Register now to join on 16 June in Brussels or virtually: https://t.co/zPuotvmpXf

[JLABS @JLABS]

Today is the day! Apply for your chance to showcase your science to J&J leadership.

Submit your big ideas aimed at changing the trajectory of neurodegenerative diseases: https://t.co/G7BoezKpq5

[Johnson & Johnson Innovation @JNJInnovation]

Last call to apply!

It’s the final day to submit your novel strategies or approaches that aim to prevent or limit the progression of neurodegenerative diseases.

Apply today: https://t.co/2gn8hLJ0vh

[JLABS @JLABS]

What area of our website do you find most beneficial?